Funding Rounds
Grey Wolf Therapeutics Series A (2018, $6M)
Grey Wolf TherapeuticsSmall molecules to increase tumor detection by the immune system.
Summary
Stage: Series A
Raised Amount: $6.30M
Raised Date: 2018-01-01
Stage: Series A
Raised Amount: $6.30M
Raised Date: 2018-01-01
